$ALDX
Aldeyra Therapeutics, Inc.
XNAS
$1.35
▼-7.53%-$0.110
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateWhy is ALDX down today? It is at $1.35 (-7.53%), and our scanner flagged it 17 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment ALDX spikes, and full due diligence on ALDX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $ALDX 17 times in the last 30 days. Create a free account to track $ALDX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on ALDX from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Brady Todd C Officer | Bought (open market) | +250K 0.4% of company | added 17% | 1.72M | $418K at $1.67 | Jun 3, 26 |
Douglas Richard Director | Bought (open market) | +70K 0.1% of company | added 56% | 195K | $98K at $1.40 | Mar 19, 26 |
Alfieri Michael Officer | Bought (open market) | +5K | added 100% | 8K | $7K at $1.42 | Mar 18, 26 |
Alfieri Michael Officer | Bought (open market) | +3K | n/a | 3K | $13K at $5.30 | Aug 13, 25 |
Machatha Stephen Officer | Sold (automatic/other) | -22K 0.04% of company | sold 9.1% | 222K | $114K at $5.15 | Aug 11, 25 |
Perceptive Advisors Llc Beneficial Owner (10%) | Sold (automatic/other) | -3.40M 5.6% of company | sold 37% | 5.88M | $4.8M at $1.42 | Apr 3, 25 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Here is the latest on ALDX from our scanner (live price and day move above). A move this size is almost always tied to a specific catalyst. Most of the time that is an earnings report, a guidance update, or a company announcement. If none is shown above, the release may not be in our news feed yet. It will show up here as soon as it is.
ALDX last traded at $1.35, down 7.53% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Aldeyra Therapeutics, Inc. (ALDX) is next expected to report earnings on Wednesday, November 4, 2026, about 54 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The ALDX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged ALDX 17 times in the last 30 days.
ALDX (Aldeyra Therapeutics, Inc.) trades on XNAS, with a market cap of about $88M.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge ALDX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$ALDX discussion
Sign in to ask a question or join the discussion.